Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01256281 · ClinicalTrials.gov registry record · Phase 1
Regional Anesthesia for Sickle Cell Crisis Using Ultrasound in The Emergency Department: Phase I
A Phase 1 study, sponsored by Icahn School of Medicine at Mount Sinai.
- Terminated
- Registry status
- Phase 1
- Development phase
- 2
- Enrollment target
NCT01256281 is a Phase 1 study that was terminated before completion, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 2 participants.
The verdict
NCT01256281, a Phase 1 study, was terminated before completion, sponsored by Icahn School of Medicine at Mount Sinai.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 2 participants
- Enrollment target
Study Summary
The hypothesis of this study is: Femoral nerve blocks can feasibly be performed on patients with Sickle Cell Disease and painful crisis in the Emergency Department.
Interventions
- PROCEDURE Femoral Nerve Block
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2010-09 |
| Est. Completion | 2013-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01256281
The ClinicalTrials.gov registry entry for NCT01256281 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Femoral Nerve Block is the first listed.
NCT01256281 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01256281 about?
NCT01256281 is a clinical study titled "Regional Anesthesia for Sickle Cell Crisis Using Ultrasound in The Emergency Department: Phase I". The hypothesis of this study is: Femoral nerve blocks can feasibly be performed on patients with Sickle Cell Disease and painful crisis in the Emergency Department.
What is the current status of trial NCT01256281?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 2 participants. The study started on 2010-09. Estimated completion is 2013-08.
What interventions are being tested in trial NCT01256281?
The interventions under investigation include: Femoral Nerve Block (PROCEDURE).
Who is sponsoring clinical trial NCT01256281?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.